RTSN

NASD Retension Pharmaceuticals Inc
Oct 12, 2026 · 7:04 AM ET LAST TRADE Market Closed

$10.00 ↓ -0.53 (-5.03%) Trading Down from the previous close of $10.53

YTD change
-5.03%
vs 20-day SMA
N/A
vs 200-day SMA
N/A

Price ranges

Previous day
$9.66 $11.60
open $10.00 close $10.53
+$0.53 (+5.30%)
Today
$0.00 $0.00
$10.00
Past week
$0.00 $10.53
from $10.53 now $10.00
-$0.53 (-5.03%)
Past month
$0.00 $10.53
from $10.53 now $10.00
-$0.53 (-5.03%)
This year
$9.66 $11.60
from $10.53 now $10.00
-$0.53 (-5.03%)

Price & Performance

+0.00 (+0.00%) / 6M

No chart data available

Signals & Sentiment

Momentum, market sentiment, and recent alerts

N/A
  • The stock is 13.8% away from all-time highs of $11.60
  • RTSN is down 5% since the beginning of the year
  • RTSN is down 5% over the past 12 months
  • RTSN is down 5% over the past 1 month

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.5292
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $97.7M

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$13.5M
Debt$28.2K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Market cap $78.8M

Retension Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. Its product, RTN-001, is a next-generation, once-daily, oral, small molecule phosphodiesterase-5 inhibitor designed to reduce blood pressure by potentiating nitric oxide signaling, a key mechanism underlying the development and severity of hypertension. The company was founded by Eric Keller and Paul Sweetnam in 2023 and is headquartered in Falls Church, VA.

Competitor comparison

No peer group available for this symbol.

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.